677298-05-4

Upstream product

• 52409-22-0 tris-(dibenzylideneacetone)dipalladium⁽⁰⁾ 
• 677298-01-0 (7-Bromo-5-methyl-benzo[1,2,4]triazin-3-yl)-phenyl-amine 
• 23112-96-1 (2,6-dimethoxyphenyl)boronic acid 

Relevant academic research and scientific papers

Benzotriazine inhibitors of kinases

The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Vasculostatic agents and methods of use thereof

Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example, stroke, myocardial infarction, cancer, ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases, inflammatory diseases, vascular leakage syndrome, edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.